GHK-Cu is the longest-running research programme in the peptide catalogue: a tripeptide first isolated from human plasma in the early 1970s, characterised as a copper(II) complex later that decade, and still generating matrix-biology and cosmetic-science literature fifty years on. It is also the molecule where coordination chemistry — not sequence — determines almost every practical decision in the laboratory.
Where it came from
The origin story is unusual for a peptide. Work in the early 1970s on why aged liver tissue behaved differently from young tissue in culture traced activity to a low-molecular-weight factor in the plasma albumin fraction. That factor resolved to a tripeptide: glycyl-L-histidyl-L-lysine, Gly-His-Lys. The histidine imidazole plus the free N-terminal amine plus the intervening amide nitrogen form an almost ideal chelation site for copper(II), and the biologically relevant species was subsequently identified as the copper complex rather than the free peptide.
Catalogue specifications reflect the complex: CAS 89030-95-5 and a molecular weight of 403.93 Da for GHK-Cu, against roughly 340.4 Da for free GHK. That 63 Da difference is copper plus coordination, and it is the number to check on a mass spectrum when confirming that a vial contains the complex rather than the apo-peptide. Vocabulary at copper peptide and tripeptide.
A frequently repeated observation from the early literature is that plasma GHK concentration declines substantially between early adulthood and later decades. It is cited constantly and is worth treating as a historical measurement rather than a mechanism.
The coordination chemistry that governs handling
Copper(II) in GHK-Cu sits in an approximately square-planar geometry contributed by the imidazole nitrogen of histidine, the terminal amino group, and the deprotonated amide nitrogen of the peptide backbone, with the lysine side chain and solvent completing the environment. Four practical consequences follow, and they explain most of what goes wrong with copper peptides in practice.
- Colour is a readout. The complex is intensely blue in solution. Loss or change of colour indicates the coordination environment has changed — a genuinely useful, free diagnostic.
- pH matters more than for ordinary peptides. Amide nitrogen deprotonation is pH-dependent, so the complex is not equally stable across the range. Strongly acidic conditions favour dissociation.
- Chelators compete. EDTA and similar agents will strip copper. So will some buffer components. Formulation compatibility is a real experimental variable in cosmetic-science work.
- Reductants change the oxidation state. Ascorbate reduces Cu(II) toward Cu(I), which is a different species with different chemistry — a well-known incompatibility in topical formulation research.
The redox activity also cuts the other way: a bound copper centre can catalyse oxidation of susceptible residues in co-formulated partners, which is the compatibility question in any multi-component blend containing a copper peptide.
What the research has examined
| Era | Focus of published work | Model type |
|---|---|---|
| 1970s | Isolation from plasma; activity in liver tissue culture | In vitro |
| 1980s–1990s | Wound-repair models; collagen and glycosaminoglycan synthesis | Rodent and rabbit models; fibroblast culture |
| 1990s–2000s | Matrix remodelling, decorin, metalloproteinase and inhibitor balance | Fibroblast and dermal explant work |
| 2000s–2010s | Hair follicle biology; copper delivery and antioxidant enzyme systems | Cell and animal models |
| 2010s onward | Broad gene-expression profiling; small controlled cosmetic studies of topical formulations | Microarray analyses; human cosmetic trials |
The gene-expression strand deserves a note because it is frequently over-claimed. A widely cited analysis reported that GHK exposure shifted expression of a large number of genes in cultured cells. That is a real result about a cell culture transcriptome; it is not evidence of a systemic effect in an organism, and the distinction is worth preserving. Structural and mechanistic detail is in what is GHK-Cu.
The strongest human-relevant data in the whole corpus are cosmetic: small controlled studies of topical GHK-Cu formulations reporting changes in measured skin parameters. Those are genuine human studies, they are also small, short and formulation-specific, and they do not transfer to other routes.
GHK-Cu against its relatives
AHK-Cu (copper tripeptide-3, Ala-His-Lys with copper) is the closest analog and is studied more in hair-follicle contexts than in dermal matrix contexts. The single residue difference at position one changes the coordination environment subtly and the biology more than the structure suggests. The comparison is worked through in GHK-Cu vs AHK-Cu, with the analog available as AHK-Cu. Palmitoylated derivatives take a different approach again, adding a lipid tail to the GHK sequence for formulation reasons rather than to change the receptor-level story.
Formats and laboratory practicalities
GHK-Cu is supplied in larger masses than most catalogue peptides — GHK-Cu research vials come in 50, 100 and 200 mg — because its low molecular weight means a given molar quantity weighs far less. At 403.93 Da, 50 mg is roughly 124 µmol, which is an order of magnitude more molecules than 50 mg of a 4 kDa peptide would provide. Anyone comparing a copper tripeptide against a larger peptide on a mass basis is making a serious arithmetic error.
Topical research formats include GHK-Cu face serum and GHK-Cu cream, where the formulation questions above — pH, chelators, reductants, packaging light exposure — become the experiment rather than a nuisance. Delivery considerations are covered in topical peptides in cosmetic research, the category in copper peptides, and class-level context in the skin research overview.
Why it has lasted
Fifty years is a long time for a tripeptide to stay interesting. The reason is that GHK-Cu sits at an intersection: it is a peptide, a metal complex, an endogenous plasma constituent, and a formulation ingredient with actual human cosmetic data behind it. Very few molecules in the catalogue can claim all four. It is also a reminder that the metal is not an accessory — remove the copper and you have a different molecule with a different literature.